Market Trends of Gas Chromatography Industry
Pharmaceutical and Bioindustries is Expected to Hold a Significant Market Share Over the Forecast Period
- In combination with proper detectors selective to the type of analyte in the sample, gas chromatography finds application in qualitative and quantitative analysis in the pharmaceutical and biopharmaceutical industry.
- The high efficiencies of separation power, the extreme detection sensitivity while detecting small amounts of separated species, and the accuracy and precision of the data from quantitative analyses of extremely complex mixtures are the major reasons why GC is used in the pharmaceutical industry. GC analyses are also less hassle-free while automating from sample introduction to separation. As per the 2023 update by DPS Instruments Europe GmbH, various pharmaceutical Applications can be analyzed using one of the Custom GC configurations of the Series 600 Lab GC offered by the company. In addition, as per the source above, whether the analysis is done in the Lab, in the factory, or out in the field, with the use of these GC systems, pharmaceutical results remain consistent.
- In addition, GC-MS is exclusively used in the bio-analysis of blood and urine for the presence of barbiturates, alcohols, narcotics, residual solvents, drugs like anesthetics, antihistamines, anticonvulsants, and anti-epileptic drugs, sedative-hypnotics, and food items. Toxins and venoms can also be identified by GC-MS. It is extensively used in clinical toxicology as well. For instance, according to a study published in NCBI in February 2022, a GC coupled with a drift tube ion mobility spectrometer (IMS) can obtain relative percentage errors lower than 8.4% and can be a reliable, selective, and sensitive technique for the determination of psychoactive substances in oral fluids. Therefore, as a result of the aforementioned main advantages and reliable results, GC is extensively used for quality control purposes in the pharmaceutical and biotechnology industries. Hence, the above-mentioned factors are anticipated to fuel the segment's growth over the forecast period.
Understand The Key Trends Shaping This Market
Download PDF
North America is Expected to Hold a Significant Share of the Market During the Forecast Period
- North America is expected to hold a major share of the gas chromatography market during the forecast period, owing to the increasing adoption of GC techniques and increasing research in the pharmaceutical and biopharmaceutical sectors. In addition, chromatography instrumentation has proven to be an effective technology for final production testing, pharmaceutical applications, environmental monitoring, and food testing, among others. Other factors propelling the growth of the market in the region include the rising prevalence of chronic diseases coupled with the increasing need for drug discovery and the augmented demand for personalized medicines.
- The increasing focus on the research and development (R&D) of improved and novel drug assessment techniques, which have been used to discover highly complex drugs, is playing a vital role in the evolution of new chromatographic methods in the region. For instance, in June 2022, Focussed Photonics, Inc. launched an industrial online gas chromatography analyzer that is distinct from the conventional laboratory setting chromatography. It uses a high-precision program-controlled column-cutting technology and column system sampling technology through which the measured components can be analyzed and obtained swiftly. Such developments are expected to drive the market growth in the region.
- Furthermore, the increased adoption of chromatography techniques, majorly in the food and beverage and pharmaceutical industries, drives the demand for GC in the region. With the rising number of critical diseases, the R&D investments in the pharmaceutical industry for drug discovery and production are increasing, which has further increased the demand for chromatography techniques in North America. For instance, as per the data updated by the Pharmaceutical Research and Manufacturers of America (PhRMA) trade group, in 2021, the R&D expenditure of its member companies reached nearly USD 79,610 2021, which increased from USD 72,412 in the previous year in the country. This high expenditure on pharmaceuticals in the country is expected to contribute to new drug discovery in the United States and propel the demand for GC used for drug discovery applications. This is expected to fuel the market growth in the country and drive the overall growth of the market studied market during the forecast period.
Get Analysis on Important Geographic Markets
Download PDF
